Michael P DiGiovanna MD, PhD

Associate Professor of Medicine (Medical Oncology) and of Pharmacology

Departments & Organizations

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology

Yale Medical Group

Office of Education: LCME Academic Environment Subcommittee

Office of Student ResearchCancer Center, Yale: Breast Cancer Program; Signal TransductionPharmacologyMedical OncologySignal Transduction


Dr. DiGiovanna is a native of Long Island, NY, who graduated from Cornell University in 1984 with a B.A. and a double major in the fields of biochemistry and music. He attended Yale University from 1984 through 1990 where he was earned the MD and PhD degrees, with his PhD in Pharmacology. He continued his post-graduate training at Yale, performing internship and residency in Internal Medicine, a research post-doctoral fellowship, and a clinical fellowship in Medical Oncology. He is currently an attending physician in Medical Oncology and Associate Professor of Medicine (Oncology) and Pharmacology at Yale University. His clinical specialty is breast cancer and he conducts both clinical and laboratory-based research. His translational laboratory research is focused on signal transduction in breast cancer. He also has a leadership role in education at the Yale School of Medicine, including current roles as Director of Pharmacology Curriculum and Director of Modules (clinical pathophysiology courses).


  • Ph.D., Yale University , 1990
  • M.D., Yale University , 1990

Selected Publication

  • Koay, D.C, Zerillo, C., Narayan, M., Harris, L.N. and DiGiovanna, M.P., “Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations”, Breast Cancer Research, 12:R62 [Epub ahead of print], 2010
Download on the Apple App Store